Antihyperglycemic Medications for Cardiovascular Disease Risk Reduction
Economic Implications With Newer Agents to Reduce Cardiovascular Risk in Diabetes
Posttest
Participating Faculty
The Burden of Cardiovascular Disease in Patients with Diabetes